4531 Stock Overview
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Yuki Gosei Kogyo Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥307.00 |
| 52 Week High | JP¥359.00 |
| 52 Week Low | JP¥275.00 |
| Beta | 0.66 |
| 1 Month Change | -4.36% |
| 3 Month Change | 8.10% |
| 1 Year Change | 6.23% |
| 3 Year Change | 5.86% |
| 5 Year Change | 23.79% |
| Change since IPO | -56.14% |
Recent News & Updates
Shareholder Returns
| 4531 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 6.2% | -1.2% | -1.0% |
| 1Y | 6.2% | 27.3% | 27.9% |
Return vs Industry: 4531 underperformed the JP Chemicals industry which returned 27.3% over the past year.
Return vs Market: 4531 underperformed the JP Market which returned 27.9% over the past year.
Price Volatility
| 4531 volatility | |
|---|---|
| 4531 Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4531 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4531's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 295 | Seiichiro Matsumoto | www.yuki-gosei.co.jp |
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients.
Yuki Gosei Kogyo Co., Ltd. Fundamentals Summary
| 4531 fundamental statistics | |
|---|---|
| Market cap | JP¥6.70b |
| Earnings (TTM) | JP¥634.00m |
| Revenue (TTM) | JP¥12.75b |
10.6x
P/E Ratio0.5x
P/S RatioIs 4531 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4531 income statement (TTM) | |
|---|---|
| Revenue | JP¥12.75b |
| Cost of Revenue | JP¥9.80b |
| Gross Profit | JP¥2.96b |
| Other Expenses | JP¥2.32b |
| Earnings | JP¥634.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 29.05 |
| Gross Margin | 23.18% |
| Net Profit Margin | 4.97% |
| Debt/Equity Ratio | 46.9% |
How did 4531 perform over the long term?
See historical performance and comparison